Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Want to earn quickly? Discover safe ways to earn money fast without scams and secure your finances.
22,263 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Backyard barbecues for 10 people now average $161, according to a Wells Fargo report. Hamburger beef leads price hike...
Meta Platforms is accelerating its real-time ai push, aiming to turn data streams into immediate monetization. With 2...
Equity futures fell and oil surged as the initial round of U.S.-Iran talks began, setting a tense tone for markets an...
Gold climbs to record highs while platinum remains weak, spotlighting a little-known platinum ETF that sits at the ce...
As Medicare premiums rise with MAGI, high earners are rethinking when to take Social Security and how to draw from ta...
In 2026, higher-income retirees still face IRMAA charges on Medicare Part D, even if their pension pays part premium....
NVIDIA trades around the $200 level as AI-chip sentiment wobbles. The next move—breakout or breakdown— hinges on upco...
PIMCO dismisses Trump’s NATO exit threats as noise, calling them a paper tiger. The note arrives as investors weigh t...
Enrollment of international students fell sharply as policy shifts took hold, triggering sharp revenue declines for c...
Credit models are evolving as BNPL usage, rent payment history, and trended data tighten the grip on underwriting. Th...
Apple shares fell sharply as memory costs tied to AI infrastructure pressured margins and prompted price bumps on sel...